Integrated Machine Learning and CT Angiography Helps Predict MACE: Study

Written By :  MD Bureau
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2021-05-09 17:45 GMT   |   Update On 2022-10-04 12:05 GMT

Coronary artery disease (CAD) is a leading cause of morbidity and mortality in the developed world. Previous studies have shown that coronary CT angiography (cCTA)-based risk scores can help predict whether patients are vulnerable to unstable angina -- and therefore heart attack -- or even cardiac death. In a study presented at the American Roentgen Ray Society (ARRS) meeting, researchers...

Login or Register to read the full article

Coronary artery disease (CAD) is a leading cause of morbidity and mortality in the developed world. Previous studies have shown that coronary CT angiography (cCTA)-based risk scores can help predict whether patients are vulnerable to unstable angina -- and therefore heart attack -- or even cardiac death. In a study presented at the American Roentgen Ray Society (ARRS) meeting, researchers have reported that integrated use of machine learning with coronary CT angiography improves the prediction of major adverse cardiac events (MACE).

Recent developments of CT scanners have improved accuracy especially regarding the visualization of the coronary arteries. A better spatial and temporal resolution makes it possible to scan the heart and the coronary arteries free of motion and to detect vascular plaques and stenoses.

"Machine learning-based cCTA-derived plaque quantification and characterization may have utility in risk-stratifying the vulnerability of coronary lesions for the prediction of future major adverse cardiac events," the researchers wrote.

Verena Brandt and her team conducted a study to evaluate the prognostic value of coronary CT angiography (cCTA)-derived plaque information and clinical parameter on the adverse cardiac outcome using machine learning (ML).

In this retrospective study, researchers analyzed datasets of 361 patients (61.9±10.3 years,65% male) with suspected coronary artery disease (CAD) who underwent cCTA. They recorded MACE more than 90 days after cCTA. They used a machine-learning algorithm trained on cCTA-derived plaque measures, conventional CT risk scores, and cardiovascular risk factors to predict adverse outcomes, measuring its performance using the area under the receiver operating characteristic curve (AUC).

Key findings of the study were:

  • Among 361 patients, the researchers observed MACE in 31 patients (8.6%) after a median follow-up of 5.4 years.
  • Upon analysis, they found that the ML model showed higher predictive power (AUC 0.96) than conventional CT risk scores including, the Agatston calcium score (AUC 0.84 ), segment involvement score (AUC 0.88), and segment stenosis score (AUC 0.89).
  • They found similar results for plaque measures (AUCs 0.72-0.82) and clinical parameters including, the Framingham risk score (AUCs 0.71-0.76).
  • They noted that the ML model yielded significantly higher diagnostic performance when compared to logistic regression analysis (AUC 0.96vs.0.92).

The authors concluded, "Integration of a ML model improves the prediction of MACE when compared to conventional CT risk scores, plaque measures and clinical information. ML algorithms may improve the integration of patient's information to improve risk stratification. ML-based cCTA-derived plaque quantification and characterization may have utility in risk-stratifying the vulnerability of coronary lesions for the prediction of future major adverse cardiac events".

For further information:

https://apps.arrs.org/AbstractsAMopen/Main/Abstract/2432


Tags:    
Article Source :  ARRS 2021 meeting

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News